Rocket Lab’s Iridium Collar Tightens as Insider Sales and Analyst Caution Compound the Selloff
Published on 07/17/2026 at 16:06 | Redaktion boerse-global.de
The narrative around Rocket Lab has split in two. On one side, engineers are making strides with the Archimedes engine for the Neutron rocket. On the other, the stock is being battered by a volatile cocktail of acquisition mechanics, analyst skepticism, and insider selling — and for the moment, finance is winning.
The shares sank to €57.00 on Thursday, a 3.55% daily drop that extended a multiweek rout. Since peaking in May at roughly $150 on US exchanges, the stock has lost more than half its value. Thursday alone saw an 11% plunge to around $67, and the July tally now stands at a 34% loss in US trading. The relative strength index has fallen to 28.6, deep into oversold territory — though previous bounces from similar levels have failed to generate lasting stabilization.
At the center of the turmoil is the planned $8 billion acquisition of Iridium Communications, announced in July. The deal is structured with a so-called collar: Iridium shareholders will receive $27 in cash plus Rocket Lab shares worth between $67.50 and $112.50 per Iridium share. If Rocket Lab’s volume-weighted average price dips below the $67.50 floor, the share component adjusts, potentially altering the economics of the transaction. That mechanism has effectively turned Rocket Lab’s stock into a takeover currency, with every price move reflecting deal math rather than operating performance.
Reports of insider sales by founder and CEO Peter Beck have added to the bearish sentiment, further unnerving investors already worried about dilution. The financing package includes a $3.6 billion bridge loan — 2.4 times the cash and marketable securities Rocket Lab held at the end of March — and investors are bracing for additional equity raisings that could water down existing holdings. The law firm Wohl & Fruchter LLP has also launched an investigation into whether the $54-per-Iridium-share consideration is fair, introducing a layer of regulatory uncertainty.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The analyst community is split on the stock’s trajectory. Piper Sandler’s Alexander Potter initiated coverage with a neutral rating and an $83 price target, arguing that Rocket Lab’s valuation looks stretched. He prefers AST SpaceMobile, which he rates overweight with a $100 target, citing a cheaper valuation and a clearer path to EBITDA profitability. Morgan Stanley, by contrast, reiterated an overweight rating and a $105 target, raising its bull-case scenario to $293. The bank sees the Iridium deal as the key to transforming Rocket Lab into a vertically integrated space platform akin to SpaceX.
Operationally, Rocket Lab continues to log progress. The company recently completed a successful test of the Archimedes engine, which delivers 1.5 million pounds of thrust and is designed for partial reusability. The first flight of the Neutron rocket is on track for the fourth quarter of 2026, though management warns that the complexity of development could trigger further delays. R&D spending on the program jumped 46% year on year to $80.5 million in the first quarter. CEO Beck has stressed that the launch will happen only when the vehicle is truly ready, not according to a fixed calendar.
The selloff was not confined to Rocket Lab. Pure-play space names such as Redwire and Intuitive Machines fell more than 10% on Thursday, while established defense primes like L3Harris and Lockheed Martin saw only modest declines. Goldman Sachs analysts note that space stocks tend to be roughly five times more volatile than the S&P 500 — a dynamic that has been on full display this month as AST SpaceMobile slumped 38% alongside Rocket Lab’s 34% drop.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
For now, the stock remains pinned near the lower end of the Iridium collar. Whether it can stabilize above the $67.50 threshold will determine the final share count Iridium holders receive — and, by extension, how much dilution existing Rocket Lab shareholders ultimately face. The Neutron engine may be firing, but the market is watching the balance sheet.
Ad
Rocket Lab Stock: New Analysis - 17 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
